MoCRA Responsible Person vs U.S. Agent: What's the Difference

The distinction that matters

Under MoCRA, the Responsible Person for a cosmetic product is the manufacturer, packer, or distributor whose name appears on that product’s label and who is responsible for submitting the product listing to FDA. A U.S. Agent, by contrast, is the domestic point of contact FDA uses for a foreign facility’s registration and communications with that facility. FDA guidance

Those roles can sit with the same service provider, but they are not the same legal function. For a foreign cosmetic brand entering the U.S., the practical question is usually not “which one replaces the other?” but “do we need both, and for which filing?” FDA cosmetics registration and listing

Why buyers confuse them

MoCRA created a product-level role that many non-U.S. brands did not have to think about before: the Responsible Person. At the same time, foreign facilities still need a U.S.-based contact in FDA registration workflows. That creates an easy but costly mix-up: teams assume the U.S. Agent can simply “be” the Responsible Person, or that naming a Responsible Person on the label satisfies the foreign-facility contact requirement.

It does not. One role is tied to who is named on the cosmetic label and who submits the product listing; the other is tied to FDA’s ability to reach a foreign facility through a U.S. contact. FDA cosmetics law overview FDA Direct user guide

Responsible Person vs U.S. Agent at a glance

FDA basis: FDA registration and listing page

How the filings actually work under MoCRA

A pattern worth naming: facility registration and product listing are connected, but they are not the same filing. Teams often treat them as one step because both happen in FDA’s cosmetics workflow, but they answer different regulatory questions.

• Facility registration is about the manufacturing or processing site. FDA says cosmetic facilities subject to MoCRA must register, update registration information within 60 days of changes, and renew registration every two years. FDA compliance policy update
• Product listing is about each marketed cosmetic product. FDA says the Responsible Person must list each marketed product, including ingredients, and provide updates annually. FDA registration and listing page
• Cosmetics Direct is FDA’s electronic portal for these submissions. FDA launched it for cosmetic facility registration and product listing, and its current user materials show both functions inside the same FDA Direct environment. FDA Constituent Update

When a foreign cosmetic brand usually needs both

If your products are made in a foreign facility and sold in the U.S., you often end up with two separate operational needs:

• a U.S. Agent attached to the foreign facility registration record, and
• a Responsible Person attached to the marketed product and reflected on the label.

That is why this confusion shows up so often in founder-led cosmetic brands. The U.S. Agent solves the FDA contact problem for the foreign facility; the Responsible Person solves the MoCRA product-listing and label-identity problem. One does not collapse into the other just because the same consultant or service company helps with both.

Three real-world examples

1) UK skincare brand selling under its own name in the U.S.

The factory in the UK needs its facility registration handled, and because it is foreign, the registration workflow includes a U.S. contact. If the brand’s own name appears on the label as the marketer or distributor, that brand is typically the Responsible Person for product listing purposes. The same outside partner may support both tasks, but the filings are still distinct.

2) Korean contract manufacturer making products for a U.S. private-label brand

The foreign manufacturing site still has the facility-side obligations. But if the U.S. private-label company’s name appears on the label, that U.S. company is usually the Responsible Person because MoCRA ties that role to the label-named manufacturer, packer, or distributor. FDA guidance

3) EU haircare company changing formulas or label details

If facility registration information changes, FDA says updates are due within 60 days. If the product listing information changes, the Responsible Person must keep that listing current through the annual update cycle. In practice, that means operations teams should track facility events and product events separately rather than treating “MoCRA compliance” as one calendar reminder. FDA Direct guide

Timing rules that tend to get missed

• Facility registration renewal: every two years for facilities required to register. FDA updated Cosmetics Direct in February 2026 to support biennial renewal tracking. FDA February 2026 update
• Facility registration changes: update within 60 days of a change. FDA cosmetics law overview
• Product listing: each marketed cosmetic product must be listed by the Responsible Person.
• Product listing updates: provide updates annually. FDA 2025 constituent update

The operational takeaway is simple: the facility has its own renewal and change-management clock, while the product listing has its own annual maintenance clock. Missing that split is what creates many avoidable compliance gaps.

Common misconceptions

The U.S. Agent is the same as the Responsible Person

No. The U.S. Agent is a contact role for a foreign facility; the Responsible Person is the label-linked party responsible for product listing under MoCRA. FDA Direct user guide

If we listed a U.S. Agent, our label is covered

No. Label obligations are separate. FDA’s cosmetics labeling rules require specific label information, and MoCRA added Responsible Person contact information requirements that need to be handled on the label side, not just in the registration portal. FDA labeling summary FDA Entry Point INCI label review

Cosmetics Direct makes the roles interchangeable

No. Using one portal does not merge the legal functions. Cosmetics Direct is the submission system; it does not erase the difference between facility registration and product listing. FDA Direct user guide

Related terms

• MoCRA: the Modernization of Cosmetics Regulation Act of 2022, which added facility registration, product listing, adverse event, records access, and other requirements for cosmetics. FDA MoCRA overview
• Cosmetics Direct: FDA’s electronic submission portal for cosmetic facility registration and product listing. FDA Direct guide
• Facility registration: the filing for a cosmetic manufacturing or processing facility subject to MoCRA, renewed every two years and updated within 60 days of changes. FDA cosmetics law overview
• Product listing: the submission the Responsible Person makes for each marketed cosmetic product, including ingredients, with annual updates. FDA registration and listing page
• INCI: International Nomenclature Cosmetic Ingredient names used for cosmetic ingredient labeling; in practice, brands use INCI review to make sure ingredient declarations and label presentation align with U.S. cosmetic labeling expectations. FDA Entry Point label review page

A practical note on implementation

Some foreign brands appoint one outside partner to act as U.S. Agent and also help with Responsible Person designation support, product listing, facility registration, and label review. FDA Entry Point publicly presents its cosmetics support that way, including U.S. Agent service, MoCRA-related registration and listing help, Responsible Person support, and INCI label review. FDA Entry Point cosmetics FAQs

That can simplify execution, especially for founder-led brands without in-house regulatory staff. The important point is structural: even when one provider supports both workflows, buyers should still verify which legal role is being filled for the facility record, which party is named on the label, and who is responsible for annual product listing upkeep.

References

• FDA — Registration & Listing of Cosmetic Product Facilities and Products
• FDA — Guidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products
• FDA — Cosmetics & U.S. Law
• FDA — FDA Direct User's Guide (Cosmetics Direct), February 2026
• FDA — Compliance Policy for Cosmetic Product Facility Registration and Cosmetic Product Listing
• FDA — Deadline for Registration and Listing of Cosmetic Product Facilities and Products
• FDA — Summary Data on Cosmetic Facility Registration and Product Listing
• FDA — Summary of Cosmetics Labeling Requirements
• FDA Entry Point — Cosmetic FAQs
• FDA Entry Point — Cosmetic Label Review (INCI)